Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without...
المؤلفون الرئيسيون: | Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Wiley
2022-07-01
|
سلاسل: | Cancer Medicine |
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1002/cam4.4644 |
مواد مشابهة
-
Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer
حسب: Mohammad Shahbazi, وآخرون
منشور في: (2023-02-01) -
Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
حسب: Puja Aggarwal, وآخرون
منشور في: (2023-01-01) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
حسب: Ryan J. Longenecker, وآخرون
منشور في: (2021-09-01) -
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
حسب: Mohammad Shahbazi, وآخرون
منشور في: (2024-11-01) -
Topical gentamicin-induced acute vestibulopathy: A case report
حسب: Teik Beng Lau, وآخرون
منشور في: (2023-05-01)